Vantage Hemp, a globally accredited plant-based extractor and finished product manufacturer, said it has obtained Good Manufacturing Practice (GMP) certification from Australia's Therapeutic Goods Administration (TGA).
The company is certified for the production of medicinal CBD extracts, isolates, and finished goods under the Pharmaceutical Inspection Co-operation Scheme (PIC/S), a manufacturing standard adopted around the world. Vantage is establishing a leadership position in key international markets by obtaining formal approval for importation through its demonstration of manufacturing excellence.
The inspection covered a wide range of aspects, including facility review, quality system, documentation, warehousing, manufacturing, packaging, quality control, equipment calibration, validation processes, and product release procedures. The final evaluation concluded that Vantage operates in accordance with the relevant GMP requirements. The Company’s ability to meet stringent regulatory requirements solidifies its reputation as a reliable and compliant manufacturer, paving the way for collaborative ventures.
"While many CBD manufacturers may boast GMP-compliant certificates from third-party organizations, Vantage was given the unique opportunity to demonstrate its compliance in front of a governing body, which is no simple feat. It’s a testament to Vantage’s commitment to quality, and required both meticulous planning and the dedication of our entire team," comments Darcie Moran, Vantage’s Director of Quality Assurance and Regulatory Affairs. "With it, our partners are assured that our manufacturing processes are in strict compliance with the most rigorous pharmaceutical standards."
This regulatory milestone is a significant asset to Vantage’s international growth strategy, opening doors to new opportunities in the Australian market and beyond.
